Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

15th Annual Diabetes Community Forum Slated for November 2, 2013 -- Topical BioMedics, Inc., Participating In Its Health & Wellness Fair
  • USA - English


News provided by

Topical BioMedics

Oct 30, 2013, 17:00 ET

Share this article

Share toX

Share this article

Share toX

The Albany ADA and its corporate partners are holding the forum for the community to raise awareness and offer support to those affected by diabetes
The Albany ADA and its corporate partners are holding the forum for the community to raise awareness and offer support to those affected by diabetes

Rhinebeck, NY (PRWEB) October 30, 2013 -- Kicking of Diabetes Awareness Month, the Albany Chapter of the American Diabetes Association’s (ADA) 15th annual Diabetes Community Forum will be presented by ShopRite on Saturday, Nov. 2 at the Holiday Inn on Wolf Rd., Albany beginning at 9 a.m. Topical BioMedics, makers of the Topricin line of natural pain relief and healing creams headquartered in Rhinebeck, NY, is participating in its Health & Wellness Fair.

Nearly 26 million Americans suffer from diabetes, and the numbers are climbing each year.

Post this

“Nearly 26 million Americans suffer from diabetes, which is the seventh leading cause of death by disease in the United States,” said ADA Director of Albany and Central New York Amy Young. “This forum for the community represents one way the local ADA is leading the fight against this deadly disease and providing support for those affected in the Capital Region and beyond.”

The program starts with a Health and Wellness Fair held from 9-10 a.m., featuring vendors offering information about the latest treatment products and services. Topical BioMedics representatives will be on hand to discuss healthy lifestyle choices and pain management options, and will be offering free samples of Topricin. The health and wellness fair will also feature cooking demonstrations and free health screenings including blood pressure, cholesterol, glucose, foot screening and diabetes risk assessment.

Introductory remarks and the keynote presentation will follow the health and wellness fair from 10-10:45 a.m., and a panel discussion will round out the morning from 10:45 a.m.-11:45 a.m.

Led by keynote speaker Kristen Caponera, a registered dietician and ShopRite employee who will present on “Nutrition from the Start,” the program also features a panel of experts involved in diabetes care and free health screenings. Panelists include: Moderator Matthew Leinung, MD, F.A.C.E., endocrinologist from Albany Medical Center; Amy Imler, CDN, RD, ShopRite; Megan Sim, PHARM D, ShopRite; Teri Hutson-Mulligan, RD, CDE, certified diabetes educator from Albany Medical Center; Marc Ginsberg, DPM, Capital Region Footcare; and, Mary Luidens, MD, assistant professor of medicine from Albany Medical College. Cooking demonstrations and sampling of healthy, diabetes-friendly recipes will be conducted by ShopRite.

Topical BioMedics teamed up with the ADA’s Saratoga 2013 Tour de Cure as a “RED RIDER” Sponsor. A Red Rider is a participant that has Type 1 or Type 2 diabetes. The Tour de Cure is the ADA’s annual cycling event that raises money to help change the future of diabetes and help stop its devastating complications. Last year’s event drew riders from New York, Massachusetts, and Vermont, and raised more than $1 million, making it the second largest fund raising ADA chapter in the country for that year.

Topical BioMedics will once again sponsor the Saratoga 2014 Tour de Cure, and is forming Team Topricin to ride in the event. Lou Paradise, the company’s president and chief of research, says, “We are pleased to join forces with the American Diabetes Association in the fight to Stop Diabetes and help raise critical funds for diabetes research, education and advocacy.”

Topricin Foot Therapy Cream is safe for diabetics, and patented for the topical treatment of neuropathy. “Unfortunately, many individuals with diabetes experience neuropathic pain, which can be extremely debilitating,” says Mr. Paradise. “Our Foot Therapy formula addresses peripheral neuropathic pain and neuroma, and is soothing and healing to the skin. Importantly, it also reduces the need/dependency for all classifications of oral pain medications, including opiates."

The Diabetic Community Forum free, but reservations are required and can be made by contacting the American Diabetes Association at 518-218-1755 ext. 3632 or by registering online at http://www.diabetes.org/communityforum.

ABOUT THE AMERICAN DIABETES ASSOCIATION:
The American Diabetes Association (ADA) is the nation’s leading nonprofit health organization whose mission is to prevent and cure diabetes and to improve the lives of all people affected by the disease. Founded in 1940, the Association serves the community by funding research to prevent, cure and manage diabetes, providing credible information about the disease, giving voice to those denied their rights because of diabetes, and delivering services to people with diabetes, their families and health care professionals. For more information, please call the American Diabetes Association at 1-800-DIABETES (1-800-342-2383) or visit http://www.diabetes.org.

ABOUT TOPICAL BIOMEDICS:
Topical BioMedics is the research and development leader in topical patented natural biomedicines for pain relief. The company’s flagship product, Topricin® Pain Relief and Healing Cream, was introduced in 1994 and is now a leading natural therapeutic brand. Designated as “The 21st century standard of care for pain management” by Woodson C. Merrell, MD (Chair, Department of Integrative Medicine, Executive Director, Continuum Center for Health & Healing, Beth Israel Medical Center), Topricin has the distinction of being the only topical patented for the treatment of the pain associated with neuropathy and fibromyalgia. Other formulas in the product line include Topricin Foot Therapy Cream and Topricin Junior for children (with 5% sales donated to pediatric cancer foundations).

All Topricin products are made in the U.S.A., formulated with approved medicines as found in the HPUS (Homeopathic Pharmacopoeia of the United States) and are in compliance with federal rules for homeopathic over-the-counter medicines. The products contain: no parabens, petroleum or harsh chemicals, are odorless, greaseless and non-irritating, and produce no known side effects, making them ideal and safe for the entire family.

Topricin is available in pharmacies, natural food stores, and retailers nationwide, including Whole Foods, The Vitamin Shoppe, Fred Meyer, Wegmans, CVS (Foot Care Section), Walgreens (Diabetic Section) and other fine stores, as well as directly from the company. For more information, visit http://www.topricin.com.

Patricia Martin, Topical BioMedics, http://www.topricin.com, (845) 871-4900 x1113, [email protected]

Modal title

Many individuals with diabetes suffer with debilitating pain from peripheral neuropathic pain and neuroma
Many individuals with diabetes suffer with debilitating pain from peripheral neuropathic pain and neuroma
Topricin Foot Therapy Cream is safe for diabetics and is patented for the topical treatment of pain associated with neuropathy
Topricin Foot Therapy Cream is safe for diabetics and is patented for the topical treatment of pain associated with neuropathy
"Nutrition from the Start" will be presented by keynote speaker Kristen Caponera, a registered dietician and ShopRite staff member
"Nutrition from the Start" will be presented by keynote speaker Kristen Caponera, a registered dietician and ShopRite staff member
Many individuals with diabetes suffer with debilitating pain from peripheral neuropathic pain and neuroma Topricin Foot Therapy Cream is safe for diabetics and is patented for the topical treatment of pain associated with neuropathy "Nutrition from the Start" will be presented by keynote speaker Kristen Caponera, a registered dietician and ShopRite staff member

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.